Search - tctmd.com

Displaying 161 - 180 of 232

Sort: Relevancy | Date

News Daily News

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

L.A. McKeown

June 17, 2014

News Daily News

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

L.A. McKeown

June 17, 2014

News Industry News

PEACE I All Comers Registry Results Demonstrate Efficacy of BIOTRONIK Pulsar-18 Self-Expanding Stent

June 13, 2014

News Industry News

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

June 11, 2014

News Daily News

Primer Estudio en Humanos ILLUMENATE: Un Nuevo Balón Recubierto de Fármacos Arroja Resultados Sólidos a los 2 Años en Lesiones de la Arteria Femoral Superficial

May 30, 2014

News Daily News

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

May 30, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

Presentation EuroPCR 2014

Post‐Market Surveillance Study of Paclitaxel‐Eluting Nitinol Stents for Treating FemoropoplitealArtery Disease in Japan: 12‐Month Results

Presenter: Hiroyoshi Yokoi

May 21, 2014

News Conference News EuroPCR 2014

EuroPCR Features PAD Therapies in Early Development and Real-World Use

Caitlin E. Cox

May 21, 2014

News Conference News EuroPCR 2014

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Caitlin E. Cox

May 21, 2014

News Daily News

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

April 14, 2014

News Daily News

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Yael L. Maxwell

February 26, 2014

News Daily News

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Yael L. Maxwell

February 26, 2014

News Industry News

Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease demonstrates superior results

February 13, 2014

News Daily News

STROLL at 3 Years: Nitinol Stent Demonstrates Sustained Patency, QoL in SFA Patients

L.A. McKeown

January 20, 2014

Presentation TCT 2013

LEVANT 2: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs. Standard Balloon Angioplasty in Diseased Femoropopliteal Arteries

Presenter: Kenneth Rosenfield

October 30, 2013

News Industry News

New Study Examines Safety and Efficacy of Drug Coated Balloon Angioplasty for Treatment of Femoropopliteal Artery Disease

October 30, 2013

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

Presentation TCT 2013

The Global Effect of Zilver PTX on Management of Femoropopliteal Disease

Presenter: Michael Dake

October 27, 2013

News Industry News

Boston Scientific Reports Favorable Clinical Trial Results Assessing The OffRoad™ Re-Entry Catheter System

October 11, 2013

Advertisement

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

PEACE I All Comers Registry Results Demonstrate Efficacy of BIOTRONIK Pulsar-18 Self-Expanding Stent

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

Primer Estudio en Humanos ILLUMENATE: Un Nuevo Balón Recubierto de Fármacos Arroja Resultados Sólidos a los 2 Años en Lesiones de la Arteria Femoral Superficial

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Post‐Market Surveillance Study of Paclitaxel‐Eluting Nitinol Stents for Treating FemoropoplitealArtery Disease in Japan: 12‐Month Results

EuroPCR Features PAD Therapies in Early Development and Real-World Use

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease demonstrates superior results

STROLL at 3 Years: Nitinol Stent Demonstrates Sustained Patency, QoL in SFA Patients

LEVANT 2: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs. Standard Balloon Angioplasty in Diseased Femoropopliteal Arteries

New Study Examines Safety and Efficacy of Drug Coated Balloon Angioplasty for Treatment of Femoropopliteal Artery Disease

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

The Global Effect of Zilver PTX on Management of Femoropopliteal Disease

Boston Scientific Reports Favorable Clinical Trial Results Assessing The OffRoad™ Re-Entry Catheter System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content